Valuations made over a number of years and subject to audit each...

Valuations made over a number of years and subject to audit each year put the mature trees product at $4500 per ... for heartwood oil.

Pharma valuations - depends upon success of Phase 3 trial and Phase 2 multiple studies progressing at the FDA.

Other revenue - use of non heartwood product - depends upon previous sales and audited assessments.

Value of trained staff and steady rise in ROE per tree.

Point is SDE - this is a LONG term investment where patience and time are needed. So if it takes until November to achieve a result it will take till then.

I am happy to wait and prefer the assessments made by professionals in Australia over hatchet jobs made under the protection of the first amendment,,,

All Imo and DYOR